Immune-Related Thyroiditis with Immune Checkpoint Inhibitors

Iyer, Priyanka C., Cabanillas, Maria E., Waguespack, Steven G., Hu, Mimi I., Thosani, Sonali, Lavis, Victor R., Busaidy, Naifa L., Subudhi, Sumit K. +2 more·2018·Thyroid
DOI 10.1089/thy.2018.0116

Cited by (239)

Items 201–239 of 239

  1. Bridging the gap between thyroidology & pediatric oncology
    Chantal Anne Lebbink · 2023
  2. Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies
    Małgorzata Bobrowicz, Magdalena Góralska, Aleksandra Kusowska, Anna Skowrońska-Szcześniak, Tomasz Bednarczuk · 2023 · Hematology in Clinical Practice
  3. Providing Clarity Regarding the Mechanism for Immune Checkpoint Inhibitor–Associated Thyroiditis
    Anupam Kotwal · 2023 · Clinical Thyroidology
  4. Painless thyroiditis induced by pembrolizumab leading to depleted pituitary hypothyroidism: a case report and literature review
    Ruona Chen, Yuqin Zhang, Yimeng Dai, Ming Zhong, Si-na Du, Haiying Zhao, Wei Li · 2023 · Research Square
  5. Endocrine Complications of the Hematologic Disorders and of Their Treatment
    Alexander Dimitrov Shinkov · 2023 · Elsevier eBooks
  6. Immune Checkpoint Inhibition
    James M. Isaacs, Afreen Idris Shariff, Jeffrey Crawford · 2023 · Springer eBooks
  7. Immuntherapie mit Checkpointinhibitoren und schilddrüsentypische Komplikationen
    Barbara Kreppel · 2024 · Angewandte Nuklearmedizin
  8. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function
    Simone De Leo · 2024 · Clinical Thyroidology
  9. Immune Checkpoint Inhibition
    James M. Isaacs, Afreen Idris Shariff, Jeffrey Crawford, Michel Georges Khouri, Meenal Kheterpal, Sarah LeNoir Sammons, Michelle Ferreira, April Wall, Jane E. Onken, Lindsay King et al. · 2024 · Springer eBooks
  10. Immunotherapy-Related Hypothyroidism: Mechanisms and Management
    Selin Çakmak Demir, Dilek Yazıcı · 2024 · IntechOpen eBooks
  11. Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations
    Carla Maria Colombo, Simone De Leo, Ilaria Campisi, Erica Palesandro, Fabio Turco, Consuelo Buttigliero, Laura Fugazzola, Marcello Tucci · 2025 · Critical Reviews in Oncology/Hematology
  12. Are patients with chronic obstructive pulmonary disease at a greater risk for the development of autoimmune thyroiditis as an adverse event of immunotherapy in non-small cell lung cancer treatment?
    Andrej Zečević, Ana Blanka-Protić, Aleksandar Jandrić, Tatjana Adžić‐Vukičević · 2025 · Pathology & Oncology Research
  13. A Clinician’s Approach to Checkpoint Inhibitor Therapy Following Inflammatory Events from Nivolumab
    Madisen Huscher, Lauren Dwyer, Danica Dodd, Jessup Kenyon · 2025 · Case Reports in Clinical Medicine
  14. Checkpoint inhibitor colitis: a gastroenterologists’ perspective
    Aditi Kumar, Hazem Alnatour, Gabriel Imbianozor, Sathiya Devi, Manel Mangalika, Philip Harvey · 2025 · Frontline Gastroenterology
  15. Graves’ Disease After Prolonged Immune Checkpoint Inhibitor Therapy
    Janki R. Patel, Conor J. Best · 2025 · Springer eBooks
  16. IMUNOTERAPIJOS SUKELTAS SKYDLIAUKĖS FUNKCIJOS SUTRIKIMAS, GYDANT AKIŲ MELANOMĄ: KLINIKINIS ATVEJIS
    Michail Taradaj, Vincas Urbonas, Lina Zabulienė · 2025 · Health Sciences
  17. Thyroiditis and Thyroid Storm
    2025 · Journal of Medical Clinical Case Reports
  18. PD-1-Ab therapeutic hypothyroidism associated with decreased of peripheral blood CD4 + T cells and addressed prophylactic medication of thyroxine administration
    Linyao Lu, Congcong Li, Wei Wei, Guanghui Ma, Xinna Zhou, Xiaoli Wang, Shuang Wang, Jun Ren · 2025 · American Journal of Physiology-Endocrinology and Metabolism
  19. The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group
    Priyanka Chandrasekhar Iyer, Nupur J. Kikani, Sonya Khan, Aysha Chaudhri, Gabriel M. Pagnotti, Conor J. Best, Steven Weitzman, Paras P Mehta, Victor Ralph Lavis, Sonali Thosani et al. · 2025 · Expert Review of Endocrinology & Metabolism
  20. Drug effects and thyroid function
    Marianne Klose, Ulla Feldt‐Rasmussen, Åse Krogh Rasmussen · 2025 · Elsevier eBooks
  21. Increasing Access and Quality Care for Immune Checkpoint Inhibitor–Related Thyroid Dysfunction
    Anne K. Brinkman, Amori Y. Salami-Henry, Lori Aaron-Brija, Faheemah M. Hannah, Mimi I-Nan Hu, Li-Ling Hwang, Rachna P. Patel, Johnny L. Rollins, Steven I. Sherman, Jessica K. Williams et al. · 2025 · JCO Oncology Practice
  22. Additional file 1 of Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients
    Hansang Baek, Jeong, Chaiho, Kabsoo Shin, Lee, Jaejun, Heysun Suh, Lim, Dong-Jun, Kang, Moo Il, Jeonghoon Ha · 2022 · Figshare
  23. Thyroid Dysfunction as a Prognostic Indicator for Overall Survival in Advanced Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors
    Xiaoping Ma, Yanling Wang, Jing Li, Zhiyi Lin, Ping Gong, Jing Fei, Min Shu, Quan Tao, Ping Dai · 2026 · Research Square
  24. Epidemiology, Predictors, and Impact of Endocrine Immune-Related Adverse Events on Outcomes in Patients with Malignant Tumors
    A. A. Kozhevnikov, Ashot Musaelovich Mkrtumyan, L. G. Zhukova, Катерина Сергеевна Гречухина, Polina S. Feoktistova, Daria Filonenko, Польшина Наталья Ивановна, Ekaterina Volkova, I.I. Rustamova, Коляго Елена Максимовна et al. · 2026 · Malignant tumours
  25. An Individualized Approach in the Management of Thyroid Dysfunction Associated with Checkpoint Inhibitors – A Clinical Case Series
    Radina Dimitrova, Mira Valentinova Siderova, Zh. Ruseva · 2026 · Acta Medica Bulgarica
  26. Radiolabelled FAPI PET imaging in the era of immunotherapy: potential role in predicting tumour response and prognosis, and detecting immune-related adverse events – a short review
    Elisabetta Perrone, Silvia Taralli, Maria Lucia Calcagni, Lucia Leccisotti · 2026 · Clinical and Translational Imaging
  27. Chronic Thyroiditis: Overview
    M. R. Sakr · 2026 · Springer eBooks
  28. Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study
    Yun Shi, Qiuyi Wang, Ziqing Ye, Doudou Chen, Taoyue Yang, Yongyue Wei, Xuqin Zheng · 2026 · Frontiers in Endocrinology
  29. Thyroid Emergencies in Critically Ill Cancer Patients
    Aysha Chaudhri, Sarimar Agosto Salgado, Sonali Thosani · 2026 · Springer eBooks
  30. Emerging mechanisms and targetable pathways in immune checkpoint inhibitor‑associated thyroid dysfunction: From pathogenesis to potential intervention
    Tianying Zhang, Hengtong Han, Hao Shi, Minghua Ma, Yating Zhang, Tingting Zhang, Libin Ma, Ze Yang, Yong-xun Zhao · 2026 · Critical Reviews in Oncology/Hematology
  31. Impact of dermatology targeted immunotherapies on autoimmune thyroid diseases: cytokine-network crosstalk and thyroid safety
    Jiahao Zhou, Ruiyang Han, Tianshu Gao · 2026 · Frontiers in Immunology
  32. Thyroid crisis following painless thyroiditis initially diagnosed as syndrome of inappropriate antidiuresis
    Miki Hamashoji, Chikayo Iwaya, Makito Tanabe, Makoto Ide, Yuji Uchizono, Yuichi Sato · 2026 · JCEM Case Reports
  33. Laboratory Medicine in Immune Checkpoint Inhibitor-Induced Autoimmune Disorders: Baseline Assessment, Diagnostic Algorithms, Monitoring, and Predictive Biomarkers
    Cecilia Matteoli, Antonino Mazzone, Roberto Verna · 2026 · Annals of Laboratory Medicine
  34. Baseline immune-organ 18F-FDG PET/CT metabolism is associated with immune-related adverse events in anti-PD-1-treated non-small cell lung cancer
    Hai-Xu Zhu, Ren-Hua Na, Xiao-Long Yao, Jureti Azhati, Li-Ming Chai, Can-Wen Sun, Bing Liu, Ze-Qiang Dai, Yan Xing · 2026 · Frontiers in Medicine
  35. Predictive value of pre-existing thyroid autoantibodies for PD-1 inhibitor-induced hypothyroidism: a retrospective cohort study
    Peiying Huang, Huangdao Yu, Xuanling Zheng, Mingzhu Lin, Fangsen Xiao, Xuejun Li, Jinyang Zeng, Fangfang Yan · 2026 · Frontiers in Endocrinology
  36. Hypothyroidism in patients treated with immune checkpoint inhibitors
    N. Laghmouch, I. Meeusen, Th.B. Twickler · 2026 · Elsevier eBooks
  37. Cell-intrinsic functions of PD-L1 activate autophagy and prevent cytokine-induced apoptosis
    Mihaela Stefan–Lifshitz, Nicola Viola, Olga Meshcheryakova, Crystal Nieves Garcia, Pamela Mattar, Zhengzi Yi, Marie Louise Aoun, John Christopher McAuliffe, Jonathan Smith, Vikas Mehta et al. · 2026 · Science Advances
  38. Immune Dysregulation and Precision Therapeutics in Hypothyroidism and Hyperthyroidism
    Faridul Haq, Waleed Alam, Seongjun Ryu · 2026 · IntechOpen eBooks
  39. Polyfunctional T Helper Cells in Checkpoint-Induced Diabetes
    Melissa Lechner · 2026 · ImmPort